Advertisement

 

 

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination – Updated Recommendations of the Advisory Committee on Immunization Practices.

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination – Updated Recommendations of the Advisory Committee on Immunization Practices.
Author Information (click to view)

Meites E, Kempe A, Markowitz LE,


Meites E, Kempe A, Markowitz LE, (click to view)

Meites E, Kempe A, Markowitz LE,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

MMWR. Morbidity and mortality weekly report 2016 12 1665(49) 1405-1408 doi 10.15585/mmwr.mm6549a5
Abstract

Vaccination against human papillomavirus (HPV) is recommended to prevent HPV infections and HPV-associated diseases, including cancers. Routine vaccination at age 11 or 12 years has been recommended by the Advisory Committee on Immunization Practices (ACIP) since 2006 for females and since 2011 for males (1,2). This report provides recommendations and guidance regarding use of HPV vaccines and updates ACIP HPV vaccination recommendations previously published in 2014 and 2015 (1,2). This report includes new recommendations for use of a 2-dose schedule for girls and boys who initiate the vaccination series at ages 9 through 14 years. Three doses remain recommended for persons who initiate the vaccination series at ages 15 through 26 years and for immunocompromised persons.

Submit a Comment

Your email address will not be published. Required fields are marked *

6 − 4 =

[ HIDE/SHOW ]